Business Insight: cell & gene therapy

Cell & Gene Therapy Insights 2021; 7(1), 35–43

10.18609/cgti.2021.011

Published: 1 February 2021

Expert Insight

Jackie Mulryne, Dr Beatriz San Martin, John Schmidt, Ewan Townsend

European legal issues stemming from the COVID-19 pandemic: regulatory, intellectual property, contract and competition law relevant to cell and gene therapy products